Profound Medical Corp.
PROF
$4.71
$0.183.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -22.64% | 492.18% | |||
| Total Other Revenue | -31.91% | -0.30% | |||
| Total Revenue | -29.26% | 30.83% | |||
| Cost of Revenue | -34.97% | 15.11% | |||
| Gross Profit | -26.58% | 39.76% | |||
| SG&A Expenses | 24.45% | -0.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.61% | 5.45% | |||
| Operating Income | -27.48% | 2.55% | |||
| Income Before Tax | -91.73% | 39.35% | |||
| Income Tax Expenses | 117.23% | -234.46% | |||
| Earnings from Continuing Operations | -101.05% | 43.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -101.05% | 43.04% | |||
| EBIT | -27.48% | 2.55% | |||
| EBITDA | -31.22% | 4.92% | |||
| EPS Basic | -72.46% | 45.77% | |||
| Normalized Basic EPS | -64.54% | 42.26% | |||
| EPS Diluted | -72.46% | 45.77% | |||
| Normalized Diluted EPS | -64.54% | 42.26% | |||
| Average Basic Shares Outstanding | 16.57% | 5.04% | |||
| Average Diluted Shares Outstanding | 16.57% | 5.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||